Your browser doesn't support javascript.
loading
Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy.
Biancini, Giovana B; Vanzin, Camila S; Rodrigues, Daiane B; Deon, Marion; Ribas, Graziela S; Barschak, Alethéa G; Manfredini, Vanusa; Netto, Cristina B O; Jardim, Laura B; Giugliani, Roberto; Vargas, Carmen R.
Affiliation
  • Biancini GB; Programa de Pós-Graduação em Ciências Biológicas:Bioquímica, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. giovana.bb@gmail.com
Biochim Biophys Acta ; 1822(2): 226-32, 2012 Feb.
Article in En | MEDLINE | ID: mdl-22085605
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Trihexosylceramides / Fabry Disease / Oxidative Stress / Enzyme Replacement Therapy Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Biochim Biophys Acta Year: 2012 Type: Article Affiliation country: Brazil
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Trihexosylceramides / Fabry Disease / Oxidative Stress / Enzyme Replacement Therapy Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Biochim Biophys Acta Year: 2012 Type: Article Affiliation country: Brazil